INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 78 filers reported holding INOZYME PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,946 | -21.8% | 16,892 | +3.7% | 0.00% | -100.0% |
Q2 2023 | $90,746 | +212.9% | 16,292 | +128.1% | 0.00% | – |
Q1 2022 | $29,000 | -44.2% | 7,144 | -6.6% | 0.00% | – |
Q4 2021 | $52,000 | -42.9% | 7,647 | -2.9% | 0.00% | – |
Q3 2021 | $91,000 | -33.6% | 7,875 | -2.3% | 0.00% | – |
Q2 2021 | $137,000 | -1.4% | 8,062 | +15.0% | 0.00% | – |
Q1 2021 | $139,000 | +41.8% | 7,011 | +48.4% | 0.00% | – |
Q4 2020 | $98,000 | -23.4% | 4,724 | -2.8% | 0.00% | -100.0% |
Q3 2020 | $128,000 | – | 4,860 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 1,591,154 | $10,852,000 | 4.54% |
CHI Advisors LLC | 892,057 | $6,084,000 | 2.02% |
Sofinnova Investments, Inc. | 2,028,308 | $13,833,000 | 0.81% |
MPM BioImpact LLC | 302,615 | $2,064,000 | 0.38% |
NEA Management Company, LLC | 2,444,379 | $16,671,000 | 0.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,344,786 | $15,991,000 | 0.34% |
Rock Springs Capital Management LP | 868,466 | $5,923,000 | 0.14% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,013,216 | $6,910,000 | 0.13% |
Orbimed Advisors | 526,600 | $3,591,000 | 0.05% |
Overbrook Management Corp | 16,726 | $114,000 | 0.02% |